Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Travere Therapeutics Inc (NASDAQ: TVTX) was $14.84 for the day, up 0.88% from the previous closing price of $14.71. In other words, the price has increased by $0.88 from its previous closing price. On the day, 1.37 million shares were traded. TVTX stock price reached its highest trading level at $15.0 during the session, while it also had its lowest trading level at $14.43.
Ratios:
Our analysis of TVTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.03 and its Current Ratio is at 2.05. In the meantime, Its Debt-to-Equity ratio is 12.20 whereas as Long-Term Debt/Eq ratio is at 9.94.
On June 11, 2025, Citigroup reiterated its Buy rating and also upped its target price recommendation from $35 to $32.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 01 ’25 when Inrig Jula sold 815 shares for $14.65 per share. The transaction valued at 11,940 led to the insider holds 88,787 shares of the business.
Cline Christopher R. sold 1,784 shares of TVTX for $37,553 on May 05 ’25. The CHIEF FINANCIAL OFFICER now owns 93,126 shares after completing the transaction at $21.05 per share. On May 05 ’25, another insider, Dube Eric M, who serves as the CHIEF EXECUTIVE OFFICER of the company, sold 18,924 shares for $21.05 each. As a result, the insider received 398,350 and left with 419,173 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1317863296 and an Enterprise Value of 1392532352. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.82 while its Price-to-Book (P/B) ratio in mrq is 40.14. Its current Enterprise Value per Revenue stands at 5.091 whereas that against EBITDA is -7.797.
Stock Price History:
The Beta on a monthly basis for TVTX is 0.75, which has changed by 0.8808619 over the last 52 weeks, in comparison to a change of 0.1185931 over the same period for the S&P500. Over the past 52 weeks, TVTX has reached a high of $25.29, while it has fallen to a 52-week low of $7.72. The 50-Day Moving Average of the stock is -12.11%, while the 200-Day Moving Average is calculated to be -17.10%.
Shares Statistics:
TVTX traded an average of 1.77M shares per day over the past three months and 1533140 shares per day over the past ten days. A total of 88.79M shares are outstanding, with a floating share count of 87.50M. Insiders hold about 1.47% of the company’s shares, while institutions hold 112.73% stake in the company. Shares short for TVTX as of 1749772800 were 10329311 with a Short Ratio of 5.83, compared to 1747267200 on 10434682. Therefore, it implies a Short% of Shares Outstanding of 10329311 and a Short% of Float of 11.709999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
